Summaries & Associations of Study Results
Levels from TR-522 Transplacental AZT
Target Organs and Levels of Evidence
NTP Technical Report Number 522
Produced from Chemtrack Database 05/19/05
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| AZT TRANSPLACENTAL CARCINOGENESIS STUDY 30516-87-1 |
12/09/04 | SPECIAL STUDY INVOLVING IN UTERO EXPOSURE USING AZT | In Utero AZT: 50, 100, 200, OR 300 MG/KG/DAY; 25, 25, 36, OR 46 PER GROUP | Southern Research Institute |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MM: CLEAR EVIDENCE | LUNG: ALVEOLAR/BRONCHIOLAR CARCINOMA 5/50 11/50 6/50 11/37 8/32 ALVEOLAR/BRONCHIOLAR ADENOMA OR CARCINOMA 14/50 20/50 13/50 18/37 18/32 | |||
| FM: NO EVIDENCE | ||||
Web page last updated on October 25, 2007
